<DOC>
	<DOCNO>NCT00159783</DOCNO>
	<brief_summary>Bipolar disorder characterize mood swing range high ( manic ) low ( depress ) state . Sometimes , symptoms depression mania present ( mixed episode ) . Asenapine investigational medication treatment manic mixed episode bipolar disorder . Patients complete study A7501006 ( 9 week extension study ) could continue treatment receiving : asenapine olanzapine ( medication already approve treatment bipolar mania ) 40 -week continuation study .</brief_summary>
	<brief_title>40 Week Extension Study Of Asenapine Olanzapine For Bipolar Disorder ( A7501007 ) ( COMPLETED ) ( P05857 )</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Asenapine</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Have complete asenapine 3week 9 week study treatment acute manic mix episode major protocol violations.. Patients unstable medical condition clinically significant laboratory abnormality .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>